# Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft

> **NCT06241196** · PHASE2 · UNKNOWN · sponsor: **Tanta University** · enrollment: 10 (actual)

## Conditions studied

- Immediate Implant

## Interventions

- **DEVICE:** implant
- **PROCEDURE:** Vestibular Socket Therapy
- **DRUG:** Alloderm
- **DRUG:** Xenogenic bone membrane shield
- **PROCEDURE:** Connective tissue graft

## Key facts

- **NCT ID:** NCT06241196
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06241196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06241196, "Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06241196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*